(Q31864740)

English

A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-beta) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-beta) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

author name string

R F Harrison

1

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

S Jacob

2

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

H Spillane

3

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

E Mallon

4

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

B Hennelly

5

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

75

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

23-31

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901643-5

7 January 2021

Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901643-5

7 January 2021

Isolation and structure determination of the intact sialylated N-linked carbohydrate chains of recombinant human follitropin expressed in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901643-5

7 January 2021

Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901643-5

7 January 2021

Outcome from consecutive in-vitro fertilization/intracytoplasmic sperm injection attempts in the final group treated with urinary gonadotrophins and the first group treated with recombinant follicle stimulating hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901643-5

7 January 2021

A randomized prospective study of early follicular or midluteal initiation of long protocol gonadotropin-releasing hormone in an in vitro fertilization program

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901643-5

7 January 2021

Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901643-5

7 January 2021

Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901643-5

7 January 2021

A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon((R))) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP((R))) in a fixed-dose regimen in women undergoing ovarian

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901643-5

7 January 2021

The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901643-5

7 January 2021

Should gonadotropin-releasing hormone down-regulation therapy be routine in in vitro fertilization?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901643-5

7 January 2021

A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901643-5

7 January 2021

The value of day 3 follicle-stimulating hormone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901643-5

7 January 2021

Identifiers

10.1016/S0015-0282(00)01643-5

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

release_srg3xogadzeupjigjydnmzvhoa

1 reference

https://api.fatcat.wiki/v0/release/srg3xogadzeupjigjydnmzvhoa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31864740&oldid=1844834015"